Skip to main content
. 2016 Nov 7;28(4):1314–1325. doi: 10.1681/ASN.2016030285

Figure 2.

Figure 2.

Kaplan–Meier analysis of 10-year outcomes according to calcineurin inhibitor. (A) Ten-year incidence of the triple composite outcome, (B) 10-year incidence of acute rejection, and (C) 10-year incidence of death-censored allograft loss. Comparisons between survival curves were made using the log-rank test. CsA, cyclosporin; FK, tacrolimus.